🇺🇸 Aromatase inhibitor and GnRH analog in United States

Aromatase inhibitor and GnRH analog (Aromatase inhibitor and GnRH analog) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Aromatase inhibitor and GnRH analog in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Aromatase inhibitor and GnRH analog approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Aromatase inhibitor and GnRH analog in United States?

Centre for Endocrinology and Reproductive Medicine, Italy is the originator. The local marketing authorisation holder may differ — check the official source linked above.